|Anthony P. Bihl III
Chief Executive Officer
Anthony P. Bihl III has more than 30 years of experience in operations and business unit leadership across the global medical device market.
He was appointed Chief Executive Officer of Bioventus LLC in December 2013. Prior to that, Bihl was Group President of American Medical Systems, a subsidiary of Endo Pharmaceuticals (“Endo”), from June 2011 through June 2012. Bihl was President & Chief Executive Officer and director of AMS from April 2008 until Endo acquired AMS in June 2011. Bihl served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics from January to November 2007, and as President of the Diagnostics Division of Bayer HealthCare from 2004 through 2006. Prior to that, he served in a number of operations and finance roles at Bayer Healthcare, and over a 20-year career in various Medical Products divisions at E.I. DuPont.
He currently holds Board seats and provides strategic leadership for Nuvectra Inc., Spectral Medical Inc., The Arthritis Foundation, as well as the Bioventus Board of Managers.
Bihl received his Bachelor of Science with distinction degree from Pennsylvania State University.